These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Comparison of paroxetine and dapoxetine, a novel selective serotonin reuptake inhibitor in the treatment of premature ejaculation. Simsek A; Kirecci SL; Kucuktopcu O; Ozgor F; Akbulut MF; Sarilar O; Ozkuvanci U; Gurbuz ZG Asian J Androl; 2014; 16(5):725-7. PubMed ID: 24830690 [TBL] [Abstract][Full Text] [Related]
43. Dapoxetine for the treatment of premature ejaculation: a meta-analysis of randomized controlled trials with trial sequential analysis. Li J; Liu D; Wu J; Fan X; Dong Q Ann Saudi Med; 2018; 38(5):366-375. PubMed ID: 30284992 [TBL] [Abstract][Full Text] [Related]
45. An overview of pharmacotherapy in premature ejaculation. Porst H J Sex Med; 2011 Oct; 8 Suppl 4():335-41. PubMed ID: 21967395 [TBL] [Abstract][Full Text] [Related]
46. Impact of physical activity on patient self-reported outcomes of lifelong premature ejaculation patients: Results of a prospective, randomised, sham-controlled trial. Kilinc MF; Aydogmus Y; Yildiz Y; Doluoglu OG Andrologia; 2018 Feb; 50(1):. PubMed ID: 28261848 [TBL] [Abstract][Full Text] [Related]
47. [Efficacy and safety of dapoxetine in the treatment of premature ejaculation]. Chen XY; Qu YW; Wang SG Zhonghua Nan Ke Xue; 2016 May; 22(5):411-4. PubMed ID: 27416664 [TBL] [Abstract][Full Text] [Related]
49. Efficacy and Safety of "On-Demand" Dapoxetine in Treatment of Patients with Premature Ejaculation: A Meta-Analysis. Du Y; Jiang Y; Zhang J; Tian G; Zhang N; Wu D; Bai X Med Sci Monit; 2019 Jun; 25():4225-4232. PubMed ID: 31171764 [TBL] [Abstract][Full Text] [Related]
50. Lifelong premature ejaculation: definition, serotonergic neurotransmission and drug treatment. Waldinger MD World J Urol; 2005 Jun; 23(2):102-8. PubMed ID: 15931533 [TBL] [Abstract][Full Text] [Related]
51. Antidepressant treatment of premature ejaculation: discontinuation rates and prevalence of side effects for dapoxetine and paroxetine in a naturalistic setting. Jern P; Johansson A; Piha J; Westberg L; Santtila P Int J Impot Res; 2015; 27(2):75-80. PubMed ID: 25410962 [TBL] [Abstract][Full Text] [Related]
52. Editorial comment on: Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Jannini EA Eur Urol; 2009 Apr; 55(4):967-8. PubMed ID: 19195773 [No Abstract] [Full Text] [Related]
53. Comparison of Treatment Emergent Adverse Events in Men With Premature Ejaculation Treated With Dapoxetine and Alternate Oral Treatments: Results From a Large Multinational Observational Trial. Verze P; Cai T; Magno C; Sabella F; Cucchiara V; Palmieri A; Mirone V J Sex Med; 2016 Feb; 13(2):194-9. PubMed ID: 26805941 [TBL] [Abstract][Full Text] [Related]
57. Patient reporting encouraged during monitoring of dapoxetine in New Zealand. Harrison-Woolrych M Drug Saf; 2011 Nov; 34(11):1115-6. PubMed ID: 21981438 [No Abstract] [Full Text] [Related]
58. Selective serotonin reuptake inhibitors in the treatment of premature ejaculation. Wang WF; Chang L; Minhas S; Ralph DJ Chin Med J (Engl); 2007 Jun; 120(11):1000-6. PubMed ID: 17624269 [TBL] [Abstract][Full Text] [Related]
59. Distress, disease, desire: perspectives on the medicalisation of premature ejaculation. Söderfeldt Y; Droppe A; Ohnhäuser T J Med Ethics; 2017 Dec; 43(12):865-866. PubMed ID: 28341756 [TBL] [Abstract][Full Text] [Related]
60. The role of dapoxetine hydrochloride on-demand for the treatment of men with premature ejaculation. De Hong C; Ren LL; Yu H; Qiang W Sci Rep; 2014 Dec; 4():7269. PubMed ID: 25434754 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]